Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States.
about
Macrolide Resistance in Streptococcus pneumoniaeRapid pneumococcal evolution in response to clinical interventionsBiological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.Molecular epidemiology of penicillin-nonsusceptible Streptococcus pneumoniae among children in Greece.Role of conjugative elements in the evolution of the multidrug-resistant pandemic clone Streptococcus pneumoniaeSpain23F ST81Promiscuous signaling by a regulatory system unique to the pandemic PMEN1 pneumococcal lineage.Genetic diversity of the tet(M) gene in tetracycline-resistant clonal lineages of Streptococcus pneumoniae.Distribution of the mosaic structured murM genes among natural populations of Streptococcus pneumoniaeThe three major Spanish clones of penicillin-resistant Streptococcus pneumoniae are the most common clones recovered in recent cases of meningitis in Spain.Prophage carriage as a molecular epidemiological marker in Streptococcus pneumoniae.Molecular evolution in a multidrug-resistant lineage of Streptococcus pneumoniae: emergence of strains belonging to the serotype 6B Icelandic clone that lost antibiotic resistance traitsNomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.Pneumococcal carriage in children in The Netherlands: a molecular epidemiological study.Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South AfricaAntimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanismsEvidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape.The murMN operon: a functional link between antibiotic resistance and antibiotic tolerance in Streptococcuspneumoniae.Emergence of a Streptococcus pneumoniae clinical isolate highly resistant to telithromycin and fluoroquinolones.Molecular epidemiology of pneumococcal carriage among children with upper respiratory tract infections in Hanoi, Vietnam.Molecular epidemiology of penicillin-susceptible non-beta-lactam-resistant Streptococcus pneumoniae isolates from Greek children.Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae.International pneumococcal clones match or exceed the fitness of other strains despite the accumulation of antibiotic resistance.Phenotypic and molecular analysis of penicillin-nonsusceptible Streptococcus pneumoniae isolates in Poland.Inhibition of the expression of penicillin resistance in Streptococcus pneumoniae by inactivation of cell wall muropeptide branching genes.Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain.Future trends in antimicrobial chemotherapy: expert opinion on the 43rd ICAAC.Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistanceClinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime.Molecular detection of the macrolide efflux gene: to discriminate or not to discriminate between mef(A) and mef(E)Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef(A)-mediated macrolide resistanceAntimicrobial-resistant bacteria in the community setting.Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4Characterization of a Multipeptide Lantibiotic Locus in Streptococcus pneumoniae.The multidrug-resistant PMEN1 pneumococcus is a paradigm for genetic success.Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistance.Mechanisms of macrolide resistance among Streptococcus pneumoniae isolates from Russia.Genetic elements responsible for erythromycin resistance in streptococci.
P2860
Q28070243-B29E2A73-7A3A-4A51-A3D3-EEE3118C05CFQ29616646-1D6D5ED4-2692-4DC4-B526-4630D7162F08Q30251593-046CF30F-9089-4378-86F4-6E534ED92CAAQ30327577-C55BABFE-AF9E-4AD8-8F9E-39597F30D47EQ30374128-5D4936CB-408D-4084-9597-68664B2A6DE4Q30402403-4BA1B350-71CE-4FAF-84FF-0703B9D0E419Q33593820-38E21473-CF26-4E97-BACB-AF3DF040AF76Q33792544-EEB236CB-5321-4CB5-84CF-E13095C22C9CQ33962939-5FD52F68-29A0-4333-9535-F97A37DC2562Q33963032-2F14A17C-E31E-4C6D-BDF8-41814F8454FAQ33966335-55495C1C-03E2-41B0-AF4F-515821ED4AADQ33972906-B96C2AAB-A8AD-4E99-8C98-37B938832C8DQ33973455-D92FE2C6-1A53-4503-9E9B-6B21AC673868Q33980212-F70815C9-594C-464C-AFFA-0E24C3CA6240Q33982164-48CBD855-5372-4DD3-9B85-E20A7645A025Q33982256-48D60D6E-45A1-432E-862A-6E15EA520CE6Q33982849-B2808D04-A3AD-4D1E-B510-008118036BA0Q34007220-9ABE0E51-D76C-4C00-8052-82CB75DBB97FQ34010162-45507EEC-0F13-4F4D-8340-BA2B07146DFFQ34143934-7818EC67-3A85-4D45-BAFC-721431E7FBC7Q34437804-FAB0CEC6-2ED3-433B-8184-E116FCCDD75FQ34948948-76B932EE-BEFF-40BD-AE65-C0CDB5AD65C9Q35026714-D208662B-8D22-4943-A648-A53D10440C06Q35103743-DDBA2AB6-5355-47A2-8056-5FADCFCB890CQ35270677-369EDFC3-BDBC-4D4A-9E4B-D24FD43D5023Q35635737-1D86E446-93BD-40C7-B492-F78ACF04C0EFQ35700261-701FBFB6-4782-47B1-9EFD-C0FB37781893Q35880792-2639767A-ACA0-4B7E-A757-827BB41E5C02Q35964560-612FC874-F155-482C-B8C3-0B5FB14E37B3Q36009392-25006F8C-B17F-403F-BED1-0F1FA766DB0FQ36048514-45CB80E5-3F1D-4629-AE71-7F346C976187Q36081307-44435018-239E-43C4-B164-5EDD74EECC2DQ36241325-0913F1AF-6DD5-4917-966B-3C021D73BDA9Q36343555-B61BFE88-64F3-4A18-9F59-851A43B23841Q36487417-2587AC9A-C340-42CC-BBEB-DDD319BF3BAFQ36548242-9112295D-4B40-4C16-8F49-172A5292D91CQ36633083-ECE5E4F7-9917-4055-89B4-EF3B2D4DB6EAQ36670897-92B1F6B3-009F-434B-8973-F0EE7C0E92A1Q36703015-BD1AC7A3-FC33-4D63-B904-FCFF3DBC1359Q37322929-993A00C0-5CDD-4389-8EAA-20C3D6D43570
P2860
Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Molecular characterization of ...... disease in the United States.
@en
Molecular characterization of ...... disease in the United States.
@nl
type
label
Molecular characterization of ...... disease in the United States.
@en
Molecular characterization of ...... disease in the United States.
@nl
prefLabel
Molecular characterization of ...... disease in the United States.
@en
Molecular characterization of ...... disease in the United States.
@nl
P2093
P356
P1476
Molecular characterization of ...... disease in the United States.
@en
P2093
P304
P356
10.1089/MDR.1998.4.325
P577
1998-01-01T00:00:00Z